# IGF::OT::IGF THE NATIONAL MYELODYSPLASTIC SYNDROMES (MDS) NATURAL HISTORY STUDY, CENTRAL LAB AND BIOREPOSITORY (CLB), TASK ORDER 03, SEPTEMBER 1, 2016-FEBRUARY 28, 2018

> **NIH NIH N01** · H. LEE MOFFITT CANCER CTR & RES INST · 2024 · $1,186,324

## Abstract

The objective of the National Myelodysplastic Syndromes Natural History Study Central Laboratory and Biorepository (The National MDS Study CL/B) is to provide the necessary scientific knowledge, technical expertise and laboratory facilities to design, build, and store a quality biospecimen collection. The National MDS Study is a seven year observational study of 2000 adults newly diagnosed with MDS and up to 500 age-matched participants who are not diagnosed with MDS, but who are clinically suspected of having this syndrome. The National MDS Study will be comprised of one Data Coordinating Center (DCC) funded under a separate contract and one CL/B. Overall coordination of the program will be performed by the DCC.

## Key facts

- **NIH application ID:** 11053256
- **Project number:** 268201400003I-P00006-26800003-1
- **Recipient organization:** H. LEE MOFFITT CANCER CTR & RES INST
- **Principal Investigator:** Pearlie K Burnette
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $1,186,324
- **Award type:** —
- **Project period:** 2016-09-01 → 2025-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11053256

## Citation

> US National Institutes of Health, RePORTER application 11053256, IGF::OT::IGF THE NATIONAL MYELODYSPLASTIC SYNDROMES (MDS) NATURAL HISTORY STUDY, CENTRAL LAB AND BIOREPOSITORY (CLB), TASK ORDER 03, SEPTEMBER 1, 2016-FEBRUARY 28, 2018 (268201400003I-P00006-26800003-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/11053256. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*